Phase II study of biweekly docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer.

Abstract

OBJECTIVE This phase II study evaluated the toxicity and efficacy of a novel dosing schedule of docetaxel and S-1 as treatment for advanced gastric cancer. METHODS Patients with measurable advanced or recurrent gastric cancer and no prior exposure to the investigational drugs were treated with intravenous docetaxel 35 mg/m(2) on days 1 and 15, and oral S… (More)
DOI: 10.1159/000226111

Topics

3 Figures and Tables

Cite this paper

@article{Kakeji2009PhaseIS, title={Phase II study of biweekly docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer.}, author={Yoshihiro Kakeji and Eiji Oki and Akinori Egashira and Noriaki Sadanaga and Ikuo Takahashi and Masaru Morita and Yasunori Emi and Yoshihiko Maehara}, journal={Oncology}, year={2009}, volume={77 1}, pages={49-52} }